Kenvue Inc.KVUENYSE

Overview Intelligence Charts News Fundamentals Key Metrics Earnings Growth Financials Insiders

Revenue (LTM)

$15.1B

-2.1% YoY

Net Income (LTM)

$1.5B

+42.7% YoY

Free Cash Flow

$1.7B

Revenue CAGR (5Y)

+0.9%

—Marginsstable

FCF$1.7B

Profitable

Watch on earnings:Organic sales growth excluding FX and divestitures, with focus on volume versus price/mix contributionAdjusted EBITDA margin and progression toward mid-teens target as standalone company scalesFree cash flow conversion rate and working capital efficiency post-separation from J&J systemsA&P spending as percentage of sales and ROI on brand investmentMarket share gains/losses in top 10 brands representing 70%+ of revenue

Key metrics:Nielsen/IRI market share data for Tylenol (analgesics), Listerine (mouthwash), and Neutrogena (facial skincare) categories · Crude oil (CLUSD) and natural gas (NGUSD) prices driving resin and packaging costs representing 20-25% of COGS · US retail sales excluding autos (RSXFS) as proxy for mass retail traffic and consumer health spending · Consumer sentiment (UMCSENT) predicting private label switching behavior and premium product demand

Income Statement

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	15,054	14,950↓0.7%	15,444↑3.3%	15,455↑0.1%	15,124↓2.1%
Gross Profit	8,419	8,285↓1.6%	8,643↑4.3%	8,959↑3.7%	8,792↓1.9%
Operating Income	2,920	2,675↓8.4%	2,512↓6.1%	1,841↓26.7%	2,704↑46.9%
Net Income	2,078	2,064↓0.7%	1,664↓19.4%	1,030↓38.1%	1,470↑42.7%
EBITDA	3,656	3,281↓10.3%	3,175↓3.2%	2,468↓22.3%	2,935↑18.9%
EPS Diluted	1.10	1.08↓1.8%	0.87↓19.4%	0.54↓37.9%	0.76↑40.7%

Balance Sheet

⚠ Elevated debt-to-equity of 0.86 from $5.3B separation debt, limiting financial flexibility for M&A or share buybacks until deleveraging progresses

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	740	1,231↑66.4%	1,382↑12.3%	1,070↓22.6%	1,062↓0.7%
Total Current Assets	4,927	5,877↑19.3%	6,138↑4.4%	5,525↓10.0%	5,697↑3.1%
Total Assets	27,929	27,316↓2.2%	27,851↑2.0%	25,601↓8.1%	27,076↑5.8%
Total Current Liabilities	4,042	3,926↓2.9%	5,481↑39.6%	5,739↑4.7%	5,945↑3.6%
Total Liabilities	7,530	7,346↓2.4%	16,640↑126.5%	15,933↓4.2%	16,311↑2.4%
Total Equity	20,399	19,970↓2.1%	11,211↓43.9%	9,668↓13.8%	10,765↑11.3%
Total Debt	129	9,046↑6912.4%	8,427↓6.8%	8,719↑3.5%	8,524↓2.2%
Net Debt	-611	7,815↑1379.1%	7,045↓9.9%	7,649↑8.6%	7,462↓2.4%

Cash Flow Statement

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	334	2,525↑656.0%	3,168↑25.5%	1,769↓44.2%	2,197↑24.2%
Capital Expenditure	-295	-375↓27.1%	-469↓25.1%	-434↑7.5%	-475↓9.4%
Free Cash Flow	39	2,150↑5412.8%	2,699↑25.5%	1,335↓50.5%	1,722↑29.0%
Stock-Based Comp	141	137↓2.8%	188↑37.2%	254↑35.1%	136↓46.5%
Net Change in Cash	122	491↑302.5%	151↓69.2%	-312↓306.6%	-8↑97.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance